RE:Liminal BioSciences Announces Strategic Priorities For 2022 Results on 4050 Delayed another quarter - "penicillin" just not cutting it as thomvest creates perception of total failure of 4050 in telegraphed series of press releases. Clearly headed for a financing accomplishing nothing over past year. Who wins? Thomvest again. Silently take over 4050 and sell privately in 3 years under the cover of night. Wait for it.
Dibah420 wrote: More hogwash.